Publication & Citation Trends
Publications
29 total
Enhancing Clinical Remission and Reducing Health Care Utilization in Severe Eosinophilic Asthma: Real-World Benefits of Benralizumab in Belgium
Cited by 0
Semantic Scholar
Early and Sustained Asthma Control and Remission in Real‐World Patients With Severe Eosinophilic Asthma Treated With Benralizumab: XALOC‐2
Cited by 1
Semantic Scholar
Early and continued asthma control improvement in patients with severe eosinophilic asthma (SEA) over 1 year post benralizumab initiation: real-world XALOC-2 programme
Cited by 0
Semantic Scholar
Belgian real-world data confirm the potential of benralizumab to induce clinical remission in patients with severe eosinophilic asthma
Cited by 0
Semantic Scholar
Clinical remission by BMI in patients with severe eosinophilic asthma (SEA) over 1 year post benralizumab: real-world XALOC-2 programme
Cited by 2
Semantic Scholar
A Belgian real-world study indicates rapid and sustained asthma symptom control with benralizumab
Cited by 0
Semantic Scholar
Gene Expression Profiling Reveals Clear Differences Between EBV-Positive and EBV-Negative Posttransplant Lymphoproliferative Disorders
Cited by 120
OpenAlex
Clinicopathological characteristics of posttransplant lymphoproliferative disorders of T-cell origin: single-center series of nine cases and meta-analysis of 147 reported cases
Cited by 76
OpenAlex
Research Topics
Asthma and respiratory diseases
(7)
Alzheimer's disease research and treatments
(6)
Viral-associated cancers and disorders
(5)
Polyomavirus and related diseases
(5)
Lymphoma Diagnosis and Treatment
(3)
Affiliations
Vlaams Instituut voor Biotechnologie
Centre For Human Genetics
Center for Human Genetics
Puratos (Belgium)
Numerical Mechanics Applications International (Belgium)